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Abstract 
Despite the increasing knowledge in both the chemical and biological domains the assimilation and exploration of 
heterogeneous datasets, encoding information about the chemical, bioactivity and phenotypic properties of com-
pounds, remains a challenge due to requirement for overlap between chemicals assayed across the spaces. Here, we 
have constructed a novel dataset, larger than we have used in prior work, comprising 579 acute oral toxic compounds 
and 1427 non-toxic compounds derived from regulatory GHS information, along with their corresponding molecular 
and protein target descriptors and qHTS in vitro assay readouts from the Tox21 project. We found no clear association 
between the results of a FAFDrugs4 toxicophore screen and the acute oral toxicity classifications for our compound 
set; and a screen using a subset of the ToxAlerts toxicophores was also of limited utility, with only slight enrichment 
toward the toxic set (odds ratio of 1.48). We then investigated to what degree toxic and non-toxic compounds could 
be separated in each of the spaces, to compare their potential contribution to further analyses. Using an LDA projec-
tion, we found the largest degree of separation using chemical descriptors (Cohen’s d of 1.95) and the lowest degree 
of separation between toxicity classes using qHTS descriptors (Cohen’s d of 0.67). To compare the predictivity of the 
feature spaces for the toxicity endpoint, we next trained Random Forest (RF) acute oral toxicity classifiers on either 
molecular, protein target and qHTS descriptors. RFs trained on molecular and protein target descriptors were most 
predictive, with ROC AUC values of 0.80–0.92 and 0.70–0.85, respectively, across three test sets. RFs trained on both 
chemical and protein target descriptors combined exhibited similar predictive performance to the single-domain 
models (ROC AUC of 0.80–0.91). Model interpretability was improved by the inclusion of protein target descriptors, 
which allow the identification of specific targets (e.g. Retinal dehydrogenase) with literature links to toxic modes of 
action (e.g. oxidative stress). The dataset compiled in this study has been made available for future application.
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Introduction
There are two competing pressures in contemporary 
chemical risk-assessment. On the one hand, there is 
increased demand for safety data, for example under 
the EU’s REACH regulations firms are obliged to submit 
detailed risk and hazard notifications to the EU for any 
substance they introduce in significant quantity [1]. On 
the other hand, there is decreased regulatory and soci-
etal acceptance of large-scale traditional in vivo toxicity 
studies on animals; moreover, on a practical level, cover-
ing the vast regions of chemical space requiring toxicity 
data using the traditional in vivo toxicological techniques 
would be too time- and resource-intensive to be feasible 
[2]. The consequence of these pressures is an increased 
demand for novel methodologies to complement and 
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in some cases replace in vivo studies, including in silico 
computational toxicology techniques.
Conventional in silico approaches for toxicity predic-
tion include quantitative structure–toxicity relationship 
modelling, analogous to quantitative structure–activity 
relationship (QSAR) modelling, whereby machine learn-
ing technologies are applied to derive a regression or 
classification function that maps from chemical struc-
tures to their in  vivo effect [3]. These approaches have 
been extensively applied in the domain of toxicity predic-
tion, with some success in cytotoxicity [4, 5], hepatotox-
icity [6] and off-target effect prediction [7].
An extension of this approach is the integration of high-
throughput in vitro screening data and/or protein target 
annotations into predictive toxicity modelling. In com-
parison to toxicity prediction methods that only utilise 
toxicity structure/structural alerts data alone to provide 
a prediction [5, 8] these heterogenous approach operate 
under the hypothesis that chemical, protein target, and 
phenotypic data domains each contribute partially inde-
pendent and therefore complementary information about 
the potential toxic effects of a compound in vivo, and that 
utilising them in combination may therefore improve 
the performance of predictive models. Sedykh et  al. [9] 
showed that enhancing a QSAR-style toxicity model with 
in vitro qHTS data improved its performance. This tech-
nique was recently reviewed by Low et al. [10], who, while 
noting mixed success in its application thus far, expressed 
optimism that the approach would play a greater role in 
future of toxicology and drug discovery as the data and 
expertise required to implement such techniques become 
more available.
In a previous study [11], we extended this approach 
by augmenting the dataset of Sedykh et al. with protein 
target descriptors corresponding to the likelihood of a 
ligand-target interaction derived from a Bayesian pre-
diction model, representing protein target affinity pre-
dictions, and investigated the performance of Random 
Forest classification models trained to predict binary tox-
icity classes using successive integration of data domains. 
We found that, for this data set, inclusion of heterogene-
ous data domains did indeed generally tend to improve 
model performance—with a models trained using all 
three descriptor domains outperforming other combina-
tions of descriptors, with an average correct classifica-
tion rate (CCR), defined as the mean of sensitivity (true 
positive rate) and specificity (true negative rate) and 
also called the balanced accuracy, of 0.82 compared to 
0.80 for the next-best model. Models showed the most 
improvement when chemical descriptors were added to a 
model which previously lacked them. We also found that 
the improvement over chemistry-only models was a con-
sequence of more accurate extrapolation of the models’ 
applicability domain into wider chemical space. How-
ever, this study concerned only one small dataset (367 
compounds).
Despite the significant increase in data available in 
the chemical and biological domains, the development 
of models using several heterogenous data domains still 
represents a significant challenge. This is due to the colla-
tion of a suitable set, given that compounds must simul-
taneously possess readouts with overlap across several 
data types, e.g. the structural, bioactivity, phenotypic 
readout, and toxicological domains (or a subset thereof ). 
In this study, we hence made use of the wealth of toxic-
ity data made available through the Globally Harmonized 
System of Classification and Labelling (GHS) in order to 
maximise the overlap of the ToxCast and Tox21 chemical 
library [12] with a toxicity classification for modelling.
The Globally Harmonized System of Classification 
and Labelling (GHS) [13] is an international framework 
for standardising chemical health and safety informa-
tion. The GHS encompasses a broad spectrum of physi-
cal, health and environmental hazards; pertinently for 
the purposes of this study, this includes the collation of 
the outcomes of independent toxicity assessments into 
a set of categories corresponding to the severity of the 
exhibited toxicity. For three routes of exposure (dermal, 
inhalation and oral) five categories are defined, each cor-
responding to a quantitative median lethal dose  (LD50) 
interval specified in mg/kg, ppmV or mg/l as appropri-
ate, with the three most severe categories (1–3) necessi-
tating a “toxic” label, category 4 necessitating a “harmful” 
label, and category 5 requiring no label. The European 
Chemicals Agency (ECHA), Japan’s National Institute 
of Technology and Evaluation (JP NITE), New Zea-
land’s Environmental Protection Authority (NZ EPA) 
and Safe Work Australia (SWA) provide public access 
via their websites to governmentally mandated or rec-
ommended acute toxicity classifications under the GHS. 
Further, ECHA publishes the industrial submissions it 
receives under the requirements of the EU legislation, 
which include declaring GHS classifications. This data 
takes the form of the number of notifications received 
for each GHS hazard category, along with the total num-
ber of notifications received. The common classification 
standards provided by the GHS system enable the colla-
tion of acute oral toxicity data from all of these resources 
with the confidence that the data they hold are mutually 
commensurate by design. Apart from the ability to look 
up information on individual compounds, this also rep-
resents a valuable means of annotating large compound 
sets with toxicity labels as performed in this work. The 
ECHA database has been previously identified as suitable 
for toxicological data analysis [14], and GHS categories 
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have been used as a framework for defining toxicity 
thresholds for predictive modelling [15].
In the present study, we annotated 3336 of 8540 stand-
ardized chemical structures from the ToxCast and Tox21 
chemical library [16] with toxicity classifications derived 
from regulatory GHS information. We compared the 
overlap of this compound set with each GHS data source, 
and the correlations between the sources, and investi-
gated the degree to which GHS-derived toxicity clas-
sifications could be discriminated through substructure 
based screens. We then derived three sets of descrip-
tors for our compounds: molecular descriptors from 
MOE [17]; in silico-derived protein-target descriptors 
using an in-house Random Forest ligand-target predic-
tion algorithm [18]; and qHTS activity scores taken from 
the Tox21 assays disseminated via PubChem [19]. We 
sought to compare how the GHS toxicity classifications 
related to these three descriptor sets through analysing 
the nearest-neighbour distance distributions and linear 
discrimination analysis projections using the chemi-
cal and protein-target descriptors, and the Tox21 qHTS 
assay data. Finally, we defined and applied three training-
test set splits (one random, and two designed to be more 
challenging) to build and assess the performance of Ran-
dom Forest classifiers on using these different descriptor 
sets, and analysed the effect of the inclusion of the differ-




For this study, we required compound data for structures, 
targets, in  vitro results, and a toxicity endpoint, which 
necessitated data collation from multiple sources. To 
this end, we were able to collate a dataset of 3055 com-
pounds, each of which was annotated with: (1) a chemical 
structure in SMILES format, from which 2D molecular 
descriptors were calculated using MOE; (2) qHTS assay 
results from the Tox21 project published via PubChem; 
(3) protein target descriptors, representing probabilities 
of bioactivity against 109 human protein targets; and (4) 
regulator-derived GHS acute toxicity categorisation for 
oral, dermal and inhalation exposure routes.
Our starting point was the full ToxCast & Tox21 chem-
ical library [12, 20], as made available for download on 
the website of the United States’ Environmental Protec-
tion Agency [16]. From this, we discarded all compounds 
which (a) were labelled as “Mixture/Formulation”, “Poly-
mer” or “Macromolecule” in the “Substance_Type” field, 
or (b) did not possess a CAS registry number (required to 
lookup GHS categories in regulatory databases). SMILES 
strings were downloaded from PubChem for any remain-
ing compounds which did not already possess them 
using the PubChem substance IDs provided or else the 
CAS registry numbers. This process yielded a set of 8540 
compounds for which GHS toxicity annotations could be 
sought.
GHS category annotation
Authoritative GHS categorisations were derived from 
four regulatory classification databases: the harmonized 
classifications present in ECHA’s Classification and 
Labelling Inventory [21], the NZ EPA’s Classification and 
Information Database [22], the GHS classification results 
published by JP NITE [23], and SWA’s Hazardous Chemi-
cals Information [24]. (Note that while the classifications 
provided by the NZ EPA are not strictly GHS classifica-
tions, the two systems are standardized [25] such that the 
conversion of the acute toxicity categories to GHS cat-
egories is trivial). The authoritative classifications from 
ECHA, JP NITE and NZ EPA were accessed through the 
OECD’s eChemPortal service [26] via the CAS registry 
numbers of compounds; classifications from ECHA and 
JP NITE were provided directly by eChemPortal, while 
classifications from NZ EPA were indirectly provided via 
a link to the compound’s entry on the NZ EPA website. 
Classification data from SWA were not accessible via 
eChemPortal, but rather were downloaded directly from 
the SWA website as a flat file and once again matched to 
compounds via CAS registry numbers.
There are five acute toxicity categories defined by the 
GHS, ranging between category 1 (most severe) to cat-
egory 5 (least severe). However, there is no acute toxicity 
GHS category directly representing general non-toxicity, 
since even the least-toxic category represents a closed 
 LD50 interval [13]. We have therefore employed the con-
cept of “implied nontoxicity” to ensure sufficient nontoxic 
compounds were included in the dataset: as GHS clas-
sifications are intended to provide a complete and com-
prehensive overview of a chemical’s hazards, presence of 
a substance in a GHS database and absence of an acute 
toxicity category implies, according to our rationale, non-
toxicity. Therefore, we have treated any compound which 
is present in an authoritative GHS classification database, 
but which is not categorised under acute toxicity for that 
administration route, as an implied nontoxic for that 
administration route. Overall, GHS acute toxicity classifi-
cations (including implied nontoxic classifications) from 
authoritative databases were found for 2770 compounds.
For the remaining 5770 compounds, a GHS categori-
sation was instead sought using the industrial notifica-
tions submitted to ECHA’s Classification and Labelling 
inventory. Again, eChemPortal was used to connect a 
CAS registry number to an entry in the ECHA inventory. 
To minimize the impact of false positives when utilising 
Page 4 of 19Allen et al. J Cheminform           (2019) 11:36 
industrial notification data, no categorisation was applied 
unless at least 10% of all notifications included that cat-
egorisation at either the same or a more severe level (This 
is the same threshold applied by ECHA to determine 
whether to advertise a notified hazard on their website 
and via their data contributions to PubChem). Using this 
method, 1591 of the total compounds could be associated 
with a notification-derived classification. Where both 
a notification-based classification and an authoritative 
classification were available for the same compound, we 
preferred the authoritative classification and discarded 
the notification-based classifications. Overall, 566 addi-
tional compound annotations were provided through 
notification-based classifications, bringing the total num-
ber of compounds with a GHS acute toxicity classifica-
tion to 3336, or 39% of the 8540 compounds for which a 
classification was sought.
Structural preprocessing
The last stage of dataset collation was compound filtering 
and standardization, and the removal of duplicates. The 
structures as represented by the SMILES strings were 
standardized using ChemAxon’s Standardizer [27] (the 
protocol followed was: “remove fragment”, “neutralize”, 
“remove explicit hydrogens”, “clean 2D”, “mesomerize”, 
“tautomerize”). Following standardization, the resultant 
structures were filtered to retain only small organic mol-
ecules, by discarding those with no carbon atoms, those 
containing elements of atomic number 21–32, 36–52 
and > 53, and those with molecular weight over 100  Da, 
leaving 8328 structures.
Finally, a duplicate removal procedure was applied 
as follows: (1) duplicated structures were identified by 
converting standardized SMILES to InChIs [28]; (2) 
all compounds with a duplicated structure but no GHS 
annotation were discarded; (3) where only one com-
pound in a set of duplicates was also an exact duplicate of 
its unstandardized structure, that compound alone was 
retained as the closest representation of the substance 
for which a GHS annotation was found, and the others 
discarded (this only occurred for two structures); and (4) 
any remaining sets of duplicates were discarded. Follow-
ing this, 7732 substances remained, of which 3060 (40%) 
possessed GHS annotations.
Descriptor generation
For each remaining unique compound, molecular 
descriptors, protein target bioactivity probabilities, and 
qHTS-derived features were next derived as described in 
the following.
Firstly, structures were transformed to the major tau-
tomer present at pH 7.4 using ChemAxon’s Calculator 
[27]. Secondly, a set of 201 2D molecular descriptors 
were calculated using the Chemical Computing Group’s 
Molecular Operating Environment (MOE) [17].
Next, to calculate protein target affinity probability pro-
files we made use of PIDGIN v2 [18], a collection of 3394 
target prediction algorithms, trained on over 13 million 
bioactivity points, with actives (cutoff 10  μM) extracted 
from ChEMBL [29] and labelled inactives extracted 
from PubChem [19]. PIDGIN is itself a suite of predic-
tive structure-bioactivity models, providing for each 
input compound a Platt-Scaled probability of affinity for 
each target. As with any predictive model its accuracy 
depends on (in this case) the particular input structure 
and target class. For that reason, when including its out-
put in further predictive modelling, we chose to only use 
the output of reasonably reliable models whose applica-
bility domains extended into the dataset at hand in order 
to minimise the error-carried-forward. To that end, the 
performance of individual PIDGIN models on the data-
set was estimated by measuring the models’ recall on the 
overlap of the input set and known activities in its train-
ing set. Using this estimate, a well-performing model 
was defined as one which achieved a recall (i.e. propor-
tion of known actives assigned a probability of activity 
of over 50%) of at least 0.5 on the overlap of the query 
compounds and the model’s training data. Further, we fil-
tered well-performing models to retain only those with a 
training set having a mean nearest-neighbour Tanimoto 
similarity to the 7732 compound set used in this study of 
over 0.25, calculated using the circular fingerprints uti-
lised by PIDGIN for prediction. These requirements can 
be considered stringent, as only 109 human target bioac-
tivity models (3% of the total) were retained. This process 
afforded a set of annotations used as descriptors subse-
quently. To further ensure that the protein target bioac-
tivity probabilities were as accurate as possible, known 
bioactivities (i.e. those included in the training data set 
extracted from ChEMBL) for the compound set on the 
selected targets were included as probabilities of 1 (i.e. 
certainty).
Lastly, we assembled qHTS data for our compound set 
from the Tox21 assay data made publicly available via 
PubChem. First, all PubChem assay data for all 192 assays 
listed with “Tox21” as their source were downloaded 
(accessed on 23 Aug 2018). Next, less relevant assays (i.e. 
counter-screening assays, autofluorescence assays, and 
those confirmatory assays for which a summary assay 
combining its results with counter screens was also avail-
able) were discarded, leaving 76 remaining assays (Addi-
tional file  1: Table  S1). For these assays, the PubChem 
activity score was used to provide a single qHTS feature 
summarising the behaviour of a compound against an 
assay record as a continuous numerical descriptor. Such 
scores were available for nearly all compounds (7713 out 
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of 7732), but compounds for which no Tox21 scores were 
available were excluded where necessary. The activity 
score ranges from 0 to 100, with inactive compounds hav-
ing a score of 0, active compounds having a score from 
40 to 100, and inconclusive compounds having a score in 
between. The score is provided by the depositor, and the 
exact way in which the score is calculated depends on the 
assay, but it is commonly assigned based on potency, effi-
cacy, curve class or a combination of these. Where mul-
tiple scores were available for the same structure-assay 
pairing due to repeated measurements, the median score 
was used (36% of compounds had at least one repeated 
measurement). Missing values (11% of all data points) 
were assumed to be inactive, and assigned a score of 0.
The dataset collated in this study, alongside the code 
necessary for reproduction of the  results obtained, is 
made publicly available via the Additional files included 
alongside this article (Additional file 2).
Binary toxicity classes
For the purposes of defining a binary acute toxicity clas-
sification for certain analyses, we considered acute oral 
toxicity only and took the GHS categories which require 
a “toxic” (skull and crossbones) pictogram—i.e. catego-
ries 1–3—as the toxic class, and those which require no 
pictogram—i.e. category 5 and implied nontoxicity—as 
the nontoxic class. Compounds in category 4 (requiring 
a “harmful” pictogram) were treated as marginal, and 
disregarded when performing binary analyses. Follow-
ing this transformation, 2006 compounds were retained 
of which 579 were classed as toxic and 1427 as nontoxic. 
Of these, only three compounds lacked Tox21 assay 
outcomes.
Exploratory data analysis
The sources’ contributions to the final data were com-
pared by calculating the relative overlap of compounds 
between the sources, with relative overlap quantified as 
the intersection over the union. The degree to which the 
sources were commensurate with one another was con-
sidered by calculating the agreement of labels between 
the GHS acute toxicity categories of the compounds pre-
sent in both data sources (for the purposes of this anal-
ysis, implied nontoxic compounds were allocated to a 
hypothetical category 6).
The oral bioavailability of the compound set was quan-
tified by considering the fraction of compounds which 
passed Lipinski’s rule, which was calculated as part of the 
MOE [17] molecular descriptor set. The druglikeness of 
the compound set was quantified using DataWarrior’s 
[30] fragment-based druglikeness score, in which positive 
values indicate more and negative values less druglike 
structures.
Visualisation of the coverage of the dataset’s chemi-
cal space with GHS annotations was performed using 
DataWarrior’s Self-Organising Map function [30], using 
SkelSpheres fingerprints, a Gaussian neighbourhood 
function, and 100 neurons per axis (i.e. 10,000 neurons 
in total).
Toxicophore screening
The structures in the compound set were analysed for the 
presence of toxicophores using FAFDrugs4 [31] and Tox-
Alerts [32] in order to investigate the overlap of GHS tox-
icity classifications with established screens. FAFDrugs4 
is an online server designed for filtering compound 
libraries prior to in silico screening experiments and 
related modelling studies, which through the “filter unde-
sirable substructure moieties” filtration option provides 
for the identification of structures containing substruc-
tures involved in toxicity which were collated through 
a manual survey of the literature. For each compound 
screened by the FAFDrugs4 server, in addition to an 
inventory of undesirable substructures present, a quali-
tative screening outcome has been generated (one out of 
“rejected”, “intermediate” or “accepted”), which depends 
on the quantity and severity of toxicophores identified.
ToxAlerts is another online platform, available via the 
Online Chemical Modelling Environment [33], provid-
ing structural alerts for the virtual screening of chemical 
libraries to flag compounds containing toxicity-related 
substructures. In contrast to FAFDrugs4, ToxAlerts is 
an open platform allowing user-contributed alerts; how-
ever, all alerts must be accompanied by an endpoint and 
a reference and must be moderated before approval. 
ToxAlerts therefore contains a wide range of alerts and 
sources, including sets of alerts derived from literature 
and from industry. While ToxAlerts contains alerts are all 
associated with an “endpoint”, certain of these endpoints 
are generic in nature and do not relate to any defined 
toxic outcome (e.g. the endpoint “extended functional 
groups” represents structural features for use in chemical 
space analysis or as features in further modelling rather 
than a screening set [34]), and hence the full battery of 
alerts contained ToxAlerts is not itself suitable for appli-
cation as a toxicity screen. Rather, a relevant subset of 
the alerts should be employed. In this study, we used the 
alerts annotated with the “reactive, unstable, toxic” end-
point, which includes structural alerts defined by Chem-
Div, LifeChemicals and Enamine used for their internal 
compound selection purposes, which was also previously 
explored in the publication introducing ToxAlerts [32].
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Class separation analyses
We next analysed the various descriptor spaces to deter-
mine how informative each was with respect to the GHS 
toxicity labels. Nearest-neighbour distance analyses 
were performed as follows: for each compound in our 
set with a binarized toxicity, the distance to its nearest-
neighbour (the most similar compound) in its own class 
(intra-class) and to its nearest-neighbour in the other 
class (inter-class) was calculated and the two distribu-
tions compared in each space. For the molecular descrip-
tor and the protein target probability spaces, Euclidean 
distance in MOE and protein target descriptor space 
was employed to define the nearest-neighbour; for the 
Tox21 assay scores, due to the sparsity of the data matrix 
(i.e. a large proportion of zero values), Cosine distance 
was employed instead. Before calculating distances, 
the molecular descriptors were centred and scaled (this 
was unnecessary for the protein target and Tox21 assay 
descriptor sets, which are each already internally on the 
same scale). Differences in distribution were tested for 
significance using a paired t test (implemented by SciPy 
[35]), and effect size measured using Cohen’s d (i.e. the 
difference between two means divided by their pooled 
standard deviation).
The classes were next analysed to determine which pre-
dicted protein targets were more associated with toxic 
compounds. We used SciPy [35] to perform a paired 
t-test and a Kolmogorov–Smirnov test to determine 
which target probability descriptors showed a signifi-
cant difference in distribution between the two classes. 
We considered a distribution to show a significant differ-
ence where the larger of the two p values obtained was 
beneath the Bonferroni-corrected threshold equivalent 
to α = 0.05. Cohen’s d was used to quantify the effect size.
We then performed linear discriminant analyses (LDA) 
as implemented in scikit-learn [36] on the three descrip-
tor spaces to compare their relevance towards the end-
point, by assessing the degree to which a simple linear 
model might be able to separate the classes in those 
spaces. An LDA performs feature reduction (to at most 
one dimension fewer than the number of classes, i.e. to a 
single dimension in the binary class case) by deriving the 
linear transformation of the feature space which achieves 
a maximum separation of the classes; the degree to which 
the classes separate in the LDA is therefore indicative 
of the maximal extent to which the classes can be lin-
early separated in the feature space. The significance of 
the separation observed under the LDA projection was 
measured using an unpaired t-test, and the effect size 
using Cohen’s d. We examined the weights assigned to 
the original protein target descriptors by the LDA projec-
tion to determine which of these features were found to 
be more important in linearly separating the classes, and 
hence which proteins might be involved in causing toxic-
ity in man.
Predictive modelling
In order to explore the degree to which GHS-derived tox-
icity labels can be predicted using machine learning mod-
els, we defined a predictive modelling set comprising the 
compounds for which a binary acute oral toxicity class 
could be defined. Such predictive models are increasingly 
relevant to chemical hazard assessment, but the robust-
ness of any model is a reliant on the quantity and qual-
ity of the data available [37]. For evaluation of predictive 
models, we defined three test sets. Firstly, we defined a 
random test set, comprising a simple class-stratified 
random 20% subsample of the modelling set. We then 
defined two test sets to approximate a more realistic sce-
nario where a predictive model is applied to novel data: 
a rare scaffolds test set (representing novel chemistry) 
and a single source test set (indicating generalisability 
to novel datasets). The rare scaffolds test set comprised 
all those compounds having a Murcko scaffold [38] pre-
sent in the modelling set no more than twice (26% of the 
compounds), the scaffolds having been calculated using 
RDKit [39]. The single source test set comprised a further 
class-stratified random 20% subsample of the modelling 
set, but was restricted to include only compounds found 
in exactly one authoritative GHS data source. In each 
case, all compounds not included in a test set were used 
as the corresponding training set.
We applied Random Forest classification models [40] 
in the predictive modelling analysis, as implemented 
in scikit-learn [36], because they (a) are non-linear 
models (complementing the linear transformations 
performed as part of the exploratory data analysis), (b) 
are relatively quick to train, even on large numbers of 
features, (c) require little in the way of feature selec-
tion, pre-processing or parameter tuning, and (d) are 
well-studied algorithms with previous well-performing 
application in toxicity prediction [11]. For each model-
ling run, a Random Forest classification model of 200 
trees was trained on the relevant training set using 
scikit-learn default parameters: e.g. criterion (the met-
ric for selecting a split) set to “gini”, max_features (the 
number of features considered at each split) set to the 
square root of the number of features, max_depth (the 
maximum depth of each tree) set to “None” to permit 
unlimited depth. A fivefold cross-validation routine 
was employed within the training set to determine the 
optimum probability threshold (corresponding to the 
proportion of concurring trees in the ensemble) to be 
used as the decision boundary, maximising CCR. Each 
model was then applied to the relevant test set, and 
its performances assessed in terms of area under the 
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ROC curve and average precision (summarised from 
the precision-recall curve), along with the sensitivity, 
specificity and CCR achieved at the probability thresh-
old determined to be optimal from the cross-valida-
tion performed within the training set.
Finally, to demonstrate the robustness of the per-
formance statistics computed for these models, and 
the degree to which they depend upon the random 
selection of test compounds, the training-test splits 
were repeated an additional 20 times for those split-
ting methods where randomness played a role (i.e. the 
random method and the single source method). The 
modelling workflow above was undertaken the perfor-
mance recorded for each of these repeated splits.
Results and discussion
Exploratory data analysis
We firstly compared the coverage of the compound 
set derived from the ToxCast & Tox21 chemical library 
across the various sources of GHS classification data. Fig-
ure  1 shows the relative pairwise overlap (quantified as 
the intersection over union) of the presence of the com-
pounds’ CAS registry numbers in the GHS classification 
databases. We found that most pairs of GHS data sources 
overlapped by less than 60%, with the exception of the 
Safe Work Australia and the EU’s harmonized classifica-
tions, which were almost wholly overlapped. In particu-
lar, the two largest data sources contribute significant 
novel classifications: the industrial notifications to ECHA 
has a maximum overlap of 36% with another dataset, 
and the classifications from the NZ EPA has a maximum 
overlap of 41%. Hence, while the value of being able to 
collate commensurate data from multiple sources when 
assembling such a dataset can be observed, certain data 
sources are more useful than others in collating a larger 
dataset.
In order to test our assumption that GHS data from 
diverse sources may be pooled, we next compared the 
classifications obtained for compounds present in mul-
tiple data sources. Figure  2 shows the proportion of 
agreement (i.e. percentage of identical labels) between 
GHS acute toxicity categories between dermal, inhala-
tion and oral exposure routes and between each data 
source on common compounds. Two trends are observ-
able. Firstly, that a compound’s acute toxicity category of 
a given exposure route from a data source exhibits high 
Fig. 1 Overlap heatmap for common compounds across the GHS data sources. Overlap here is quantified as intersection over union. Absolute 
numbers of compounds present in each source are given in the x axis. With the exception of the ECHA and SWA data sources (SWA uses ECHA as 
one of its own sources of classification), the heatmap indicates that other data sources contribute significant quantities of unique data, illustrating 
the benefit of collating toxicity data from multiple commensurate sources
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agreement with its acute toxicity category of the same 
exposure route from other data sources; for example, 
75%, 82% and 80% of compounds exhibited agreement 
between all oral, dermal and inhalation acute toxicity 
labels, respectively. This first result is important for the 
remainder of this study, as the fact that GHS classifica-
tions for overlapping compounds exhibit high agreement 
across regulatory inventories corroborates the notion 
that GHS classifications are internationally commen-
surate (as they were intended to be) and can therefore 
be pooled from disparate sources into a coherent single 
dataset. Secondly, it can be seen that a compound’s acute 
toxicity categories across the three exposure routes are 
poorly correlated across all data sources, with only 35% of 
compounds having all annotated labels across exposure 
routes in agreement. The second result simply illustrates 
that a compound’s toxicity is strongly dependent on its 
route of exposure, and as some compounds maybe highly 
toxic via one route but harmless by another the degree 
to which acute toxicity can be correlated across exposure 
routes is limited, as has been previously observed. [41] 
Therefore, rather than attempting to consider acute tox-
icity independent of route of exposure, in the remainder 
of this study we considered acute oral toxicity only—as 
this was the route of exposure with the greatest number 
of annotations on our compound set.
We next investigated whether there was a differ-
ence in druglikeness and Lipinski’s rule failure rate 
[42] between the GHS classes and the wider ToxCast 
& Tox21 library, since it was plausible that a GHS clas-
sifications might be more often annotated for bio-
available or bioactive compounds. Figure  3 compares 
the Lipinski’s rule failure rate (serving as a proxy for 
poor bioavailability) and the fragment-based druglike-
ness score calculated through DataWarrior [30] across 
the compounds with and without acute oral toxic-
ity classifications. The results show that no large sys-
tematic differences in these properties exist between 
compounds included or not included in our com-
pound set, nor between the various GHS categories. 
Fig. 2 Agreement heatmap between GHS acute toxicity categorisations of common compounds in the GHS data sources. For the purpose of this 
analysis, implied nontoxic compounds were treated as belonging to a hypothetical category 6. The heatmap indicates that common compounds’ 
acute toxicity classifications tend to exhibit higher agreement when comparing classifications for the same route of exposure; however, agreement 
between different routes of exposure are generally substantially lower
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Although no large differences were found, there was a 
small (but significant) difference between the propor-
tion of compounds with a GHS classification (includ-
ing implied nontoxics) and those without passing the 
Lipinski filter: those with a classification were found 
to be more likely to pass, at an odds ratio of 2.80 and 
p value of 9.2 × 10−17. It is therefore feasible that, 
while compounds included in this study are no more 
or less druglike by the DataWarrior metric than those 
excluded, the compounds for which a GHS-derived 
acute oral toxicity classification could be applied will 
tend to be more bioavailable.
The distribution of GHS-derived toxicity classes 
within the chemical space of the dataset was visualized 
in through a Self-Organizing Map (Additional file  1: 
Fig. S1) in which compounds were coloured accord-
ing to their GHS acute oral toxicity classification. This 
plot illustrates that GHS categories had been derived 
for diverse subset of the chemical space described by 
the wider chemical library, although classifications 
were not uniformly distributed. The visualisation also 
reveals a small degree of clustering among the classes.
Toxicophore analyses
We next examined the degree to which GHS-derived 
toxicity classifications overlap with existing substructure-
based toxicity filters, and sought to identify particular 
substructures which would be able to screen for these 
classifications. The results of this toxicophore analysis, 
broken down by GHS acute oral toxicity class, are given 
in Fig. 4. It can be seen that there was no clear associa-
tion between the results of the FAFDrugs4 toxicophore 
screening test and the GHS acute oral toxicity cat-
egories (Fig.  4a). When the compounds are binned into 
binary toxicity classes (Fig.  4b), a larger fraction of the 
nontoxic compounds were both accepted and rejected 
by the screen compared to the toxic compounds, due 
to the increased number of “intermediate” screening 
results among the toxic compound set. As an intermedi-
ate screening result implies the presence of at least one 
toxicophore, a conservative approach might reject the 
intermediate compounds and retain only fully accepted 
compounds; in which case, it is observed that a signifi-
cantly higher proportion of nontoxic than toxic com-
pounds were accepted by the FAFDrugs4 screen although 
the effect size is very small (odds ratio 1.25, p value 0.03). 
However, because of the large proportion of “interme-
diate” results, measuring the agreement between the 
FAFDrugs4 screen and the toxicity endpoint is challeng-
ing to assess.
To complement FAFDrugs4 screen, we next used the 
ToxAlerts webserver to screen our compounds as out-
lined in the Methods section. We identified that Tox-
Alerts associated with the “reactive, unstable, toxic” 
endpoint were present in slightly larger proportions of 
compounds in the more severe acute oral toxicity cat-
egories (present in 79%, 67% and 61% of compounds in 
categories 1–3, 4 and 5, respectively) (Fig.  4c). When 
the compound set was divided into binary “toxic” and 
“nontoxic” classes (Fig. 4d), the enrichment of “reactive, 
Fig. 3 Lipinski’s rule failure rate (a) and DataWarrior fragment-based druglikeness score (b) for the structures in our compound set. Compounds 
with an available GHS-derived acute oral toxicity classification (including implied nontoxicity) more frequently pass the Lipinski filter, which 
may indicate higher bioavailability among those compounds. The distributions (median and inter-quartile range) of druglikeness among the 
classifications are very similar, though the tail length varies. Hence, we determined that the annotated compounds did not substantially differ with 
regard to their druglikeness
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unstable, toxic” toxicophores among the compounds 
annotated as toxic via GHS classifications was meas-
ured as having an Odds Ratio of 1.56 with a p value of 
1.3 × 10−4 (representing a significant enrichment, albeit 
only at a small effect size). This means that while the 
agreement between FAFDrugs4 alerts and GHS toxic-
ity labels is small, the “reactive, unstable, toxic” sub-
structures from ToxAlerts show a greater prevalence 
among toxic compounds and therefore may be impli-
cated in contributing towards these compounds’ toxic 
behaviour.
We next performed an enrichment analysis of the 
binarized toxic (GHS class 1-3) and compounds com-
pared to nontoxic (class 5 or implied nontoxic) com-
pounds for each toxicophore from ToxAlerts in the 
“reactive, unstable, toxic” set, to determine which of 
the individual substructures are associated with the 
effect. Only those enrichments with a p value below the 
Bonferroni-corrected critical value equivalent to 0.05 (i.e. 
0.5/n) were considered and the toxicophores satisfying 
this significance threshold with the largest effect size are 
given in Table 1. The identified substructures (e.g. double 
P=S and P=C bonds and thiocarbonyls) represent highly 
reactive functionalities, consistent with the nature of the 
category of “reactive, unstable, toxic” endpoints. These 
reactive moieties or their metabolites may afford covalent 
modification of biological macromolecules, as the ini-
tiating event for many toxicities is the reaction between 
a xenobiotic electrophile and the nucleophilic regions 
of important biological peptides and proteins [32, 43]. 
Hence, in this section we have identified a range of pre-
viously-known functional groups associated with toxicity 
which are present in the GHS toxic dataset.
While the substructures in the ToxAlerts server 
labelled with the “reactive, unstable, toxic” endpoint were 
enriched in compounds classed as “toxic” using GHS 
Fig. 4 The results of toxicophore screens on the compound set, using the FAFDrugs4 screen (a, b), and the “reactive, unstable, toxic” endpoint 
alerts from ToxCast (c, d). The results of the FAFDrugs4 test are unable to usefully screen for acute oral toxicity as encoded by GHS classes: in B, 
both rejection (red bar) and acceptance (green bar) is more common in nontoxic compounds. However, there is a weak relationship between 
these classes and the presence/absence of the “reactive, unstable, toxic” ToxAlerts toxicophores, as illustrated by the higher red bar for the toxic 
compounds in D
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acute oral toxicity categories, the size of the effect was 
small. Indeed, we found that the majority of our toxic and 
nontoxic compounds contained at least one relevant Tox-
Alerts alert. These findings corroborate previous findings 
in the literature concerning the limited utility of relying 
upon (non-quantitative) structural alerts for accurate 
toxicity assessment [44], not least due to the propensity 
for alerts to be present in large proportions of both toxic 
and nontoxic compounds [45]. Nonetheless, as the GHS 
is the internationally recognised standard for categorising 
and communicating chemical hazard generally and acute 
toxicity specifically, and structural alerts are a widely 
accepted technique in toxicity screening, we would have 
anticipated toxicophore analysis to be a more useful 
means of forecasting its acute oral toxicity categories.
Class separation analyses
We next analysed the relationship between the binary 
toxicity classes and the three descriptor domains, to dis-
cern to what extent the different toxicity classes can be 
distinguished in the different descriptor spaces, and thus 
provide a rationale for implementing and evaluating het-
erogenous toxicity prediction models. We hence per-
formed nearest-neighbour distance analyses to compare 
the distributions for inter- and intraclass nearest-neigh-
bours, and LDA projections maximising the interclass 
distance, in the molecular, protein target, and Tox 21 
assay score descriptor spaces (Fig. 5). We shall discuss the 
nearest-neighbour and LDA plots together, moving from 
the chemical descriptor space on to the protein target 
space, and finally onto the Tox21 descriptor space.
In molecular descriptor space the nearest-neighbour 
distance distributions (Fig.  5a) exhibit a large difference 
in distribution (Cohen’s d of 0.72, p value of 6.1 × 10−223) 
with interclass nearest-neighbour pairs being further 
from one another than intraclass pairs, which suggests 
that the binary toxicity classes exhibit a significant degree 
of neighbourhood behaviour [46] in chemical space 
(i.e. small changes in descriptors are associated with 
no change in class). Likewise, the LDA plot (Fig. 5b) for 
molecular descriptor space illustrates that a large separa-
tion of the classes can be achieved using a linear trans-
formation (Cohen’s d of 1.95, p value of 2.3 × 10−253). 
Although to a lesser extent, there is also a moderate dis-
tinction in protein target space in the nearest-neighbour 
distance distribution (Fig. 5c) (Cohen’s d of 0.70, p value 
of 4.4 × 10−167) and a comparatively higher degree of 
separation using LDA (Fig. 5d) (Cohen’s d of 1.42, p value 
of 2.8 × 10−152). Results from this analysis can be used 
to determine the protein targets (and hence biological 
mechanisms) most useful in linearly separating the toxic 
from non-toxic classes, which is a generally a benefi-
cial feature of utilising interpretable input feature space. 
Table  2 gives the five most associated protein targets 
with the toxic set of compounds along with their associ-
ated literature evidence to known mechanisms of toxic-
ity (the full list is given in Additional file 1: Table S3). All 
of the five most associated targets have confirmed links 
Table 1 Top 5 enriched “reactive, unstable, toxic” endpoint ToxAlerts substructures in the binarized toxic set (GHS acute 
oral toxicity category of 1–3) versus nontoxic set (acute oral toxicity category of 5 or implied nontoxic)
Only enrichments with a p value below the Bonferroni-corrected cut-off equivalent to α = 0.05 were considered. The remaining significant enrichments were ranked 
according to their odds-ratio, or effect size. These alerts generally represent reactive functionalities that might be anticipated to afford nonspecific toxicity
Toxicophore structure Alert ID Description Odds ratio p value Source
TA1000 Double P=S and P=C bonds 35.2 4.7 × 10−19 Enamine
TA975 Thiocarbonyls 27.6 9.6 × 10−6 Enamine
TA880 Gem-Dihalo propane and cyclopropane 25.1 3.1 × 10−5 Life chemicals
TA567 Thioureas 25.1 3.1 × 10−5 ChemDiv
TA885 Life chemicals
TA1075 Ontario institute 
for cancer 
research
TA914 Nitrosos 16.4 5.0 × 10−6 Life chemicals
TA998 Enamine
TA1089 Maybridge
Page 12 of 19Allen et al. J Cheminform           (2019) 11:36 
to toxicity, where Retinal dehydrogenase 1 and Nuclear 
factor erythroid 2-related factor 2 are linked to oxida-
tive stress (ultimately leading to apoptosis) [47, 48] while 
Nuclear receptor ROR gamma and DNA dC → dU-edit-
ing enzyme APOBEC-3F have more direct links to apop-
tosis and necrosis through their importance in cytokine 
mediate pathways [49, 50]. The vitamin D3 receptor tar-
get can be considered to have a more indirect connection 
to toxicity, although the disruption its role in  Ca2+ signal-
ling can be linked to negative regulation of cell prolifera-
tion [51]. Table  3 gives the five highest-weighted target 
probabilities in the LDA projection, where four of those 
targets have known links to toxicity. For example, the his-
tone deacetylases 5 and 6 are the highest weighted tar-
gets, and each are currently exploited in cancer therapies 
[52, 53]. Additionally, normal function of the Glucagon-
like peptide 1 receptor is required for cell proliferation 
and hence negative regulation can be linked to apoptosis 
[54]. Kappa-type opioid receptor is also one of the top 
targets from this analysis but without confirmed litera-
ture links to toxicity, which is hence a putative-toxicity 
related target which we propose could form the basis for 
future biochemical experiments.
We finally performed the nearest-neighbour and LDA 
analysis on Tox21 assay space, which shows a lower 
degree of separation on the qHTS descriptors (Fig.  5e, 
f ). The trend of intraclass nearest-neighbours tending to 
be nearer together than interclass nearest-neighbours 
was still apparent, but the two distributions were largely 
overlapping and the effect size was very small (Cohen’s d 
of 0.11, p value of 1.4 × 10−40). Despite LDA deriving a 
transformation which achieves the maximal linear sepa-
ration, still the maxima of the two classes overlapped in 
the LDA dimension, and the effect size was much less 
than for the other descriptor spaces (Cohen’s d of 0.67, 
p value of 7.5 × 10−40). These results suggested that a 
Fig. 5 Nearest-neighbour distance distributions for intra-class and inter-class pairs among compounds annotated with a binary toxicity class, and 
linear discriminant analysis projections on the same data. The molecular descriptor space is used in a, b, the protein target descriptor space in c, 
d, and the in vitro qHTS space in e, f. Larger differences in nearest-neighbour distributions and LDA projections are evident in the molecular and 
protein target descriptor spaces than in the in vitro qHTS space
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linear method of class discrimination would have limited 
applicability using the qHTS values as descriptors. We 
therefore conclude that the relationship between Tox21 
assays and acute oral toxicity is non-trivial, and that the 
biological mechanisms of toxicity represented in the 
GHS-derived classifications are not fully captured by the 
endpoints measured by Tox21; this is partially consistent 
with the findings of Huang et al. [55], who reported that 
the performance of models using Tox21 assay data with-
out chemical descriptors to model in  vivo toxicity was 
highly end point dependent, with success only for a sub-
set of endpoints studied.
Predictive modelling
We next utilized Random Forest classification mod-
els in order to evaluate how well different input feature 
spaces can be used to predict GHS classes computation-
ally. Briefly (for details see methods section), the models 
were evaluated using three test sets: a random test set, a 
rare scaffold test set (containing only compounds having 
a Murcko scaffold present no more than twice, represent-
ing novel chemistry), and a single source test set (contain-
ing compounds present in only one authoritative GHS 
data source, indicating generalisability to novel datasets). 
For each test set, models were trained on all compounds 
not included in the test set. For each training/test set 
split, models were generated using each descriptor set 
in turn. In addition, a fourth class of models were gener-
ated using a descriptor set comprising a combination of 
chemical and protein target descriptors. This resulted in 
12 models in total across three test sets and four descrip-
tor sets.
The performances of the resulting models are given in 
Table  4. Overall, we found that molecular descriptors 
provided the best predictive performance (best ROC-
AUC of 0.92). Next best were protein target descrip-
tors (best ROC-AUC of 0.85), but the models generated 
using the Tox21 assay descriptors performed poorly 
Table 2 Protein target descriptors exhibiting a  significant difference in  distribution between  binarized toxic set 
versus nontoxic set
Enrichment effect size was quantified via Cohen’s d, and the top 5 targets with the largest effect size indicating more association with the toxic set are shown. Only 
enrichments with a p value below the Bonferroni-corrected threshold equivalent to α = 0.05 were considered. The full table is given in Additional file 11: Table S3. The 
relevance of these targets to toxicity is explored in the text
Uniprot Protein Class Cohen’s d p value Relevant function [associated 
pathologies]
Refs.




P51449 Nuclear receptor ROR gamma Nuclear hormone receptor 0.37 1.4 × 10−13 Cytokine-mediated signaling 
pathways [apoptosis]
[49]
Q16236 Nuclear factor erythroid 2-related 
factor 2
Transcription factor 0.36 5.5 × 10−13 Regulation of cellular redox condi-
tions [oxidative stress]
[48]
Q8IUX4 DNA dC → dU-editing enzyme 
APOBEC-3F
Hydrolase 0.33 1.5 × 10−7 DNA mutators participating in the 
innate immune system [inducing 
mutations > apoptosis/necrosis]
[50]
P11473 (pidgin) Vitamin D3 receptor Nuclear hormone receptor 0.28 1.0 × 10−8 Ca2+ signalling [negative regula-
tion of cell proliferation]
[51]
Table 3 Top 5 highest-weighted human target descriptors in  the  linear discriminant analysis projection used 
to discriminate between binarized toxic and nontoxic classes
The relevance of these targets to toxicity is explored in the text
Uniprot Protein Class Weight 
(absolute)
Relevant function [Associated pathologies] Refs.
Q9UQL6 Histone deacetylase 5 Hydrolase 5.45 Chromatin organisation [Negative regulation of cell cycle/apoptosis] [52]
Q9UBN7 Histone deacetylase 6 Hydrolase 5.19 Chromatin organisation [Negative regulation of cell cycle/apoptosis] [53]
P41145 Kappa-type opioid receptor 3.02 Central to nerutotranmitter activity i.e.—acetylcholine transport
GPCR not the most toxic—could link it to pain [n/a]
P43220 Glucagon-like peptide 1 receptor 2.60 Activation of cell proliferation [apoptosis] [54]
P11473 Vitamin D3 receptor Nuclear 
hormone 
receptor
2.20 Ca2+ signalling [negative regulation of cell proliferation] [51]
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(best ROC-AUC of 0.57). As a consequence of these 
results, we elected to generate a fourth class of model, 
trained using a combination of molecular and protein 
target descriptors.
These results are visualised in Fig.  6 (ROC and preci-
sion-recall curves for each model are provided in Addi-
tional file 1: Fig. S2 and S3). It can be observed that the 
models trained using MOE 2D molecular descriptors 
as features (leftmost, blue bars) exhibited the strongest 
predictive performance across all three test sets, with 
a maximum ROC AUC of 0.92 for the random test set 
and a minimum of 0.80 for the rare scaffolds test set. 
At the optimal threshold, the model exhibited a CCR 
of 0.85–0.72 across the three test sets. The strong per-
formance of the model is gratifying in that it illustrates 
that a relationship can be found between compound 
chemistry and GHS-derived toxicity classification—in 
contrast to the relationship between these classifica-
tions and structural alerts or toxicophores, which was 
earlier shown to be weak. The rare scaffold test set pro-
vided the greatest challenge to the models, eliciting the 
weakest performance in the majority of metrics. We 
Table 4 Summary of  Random Forest classifier performances across  the  three different test sets and  the  four different 
combinations of descriptors
Generally, the best performing models were those trained using either molecular descriptors alone or in combination with protein target descriptors. Classifiers found 
the random test set less challenging to predict than the two more challenging test sets
Test set Descriptors ROC AUC Average 
precision
Sensitivity Specificity CCR 
Random Molecular 0.92 0.83 0.92 0.78 0.85
Protein target 0.85 0.71 0.81 0.73 0.77
Tox21 assay 0.60 0.40 0.47 0.67 0.57
Molecular and protein target 0.91 0.82 0.85 0.79 0.82
Rare scaffolds Molecular 0.80 0.68 0.64 0.81 0.72
Protein target 0.70 0.51 0.70 0.59 0.65
Tox21 assay 0.57 0.36 0.67 0.43 0.55
Molecular and protein target 0.80 0.68 0.83 0.63 0.73
Single source Molecular 0.83 0.65 0.70 0.81 0.75
Protein target 0.79 0.63 0.76 0.67 0.72
Tox21 assay 0.61 0.39 0.43 0.73 0.58
Molecular and protein target 0.85 0.69 0.77 0.76 0.76
Fig. 6 Performance of the four classes of Random Forest classifiers trained on the dataset, quantified by ROC AUC, average precision, and the 
sensitivity, selectivity and CCR achieved at the optimal prediction threshold, across the three training-test set splits. It can be observed that the 
best-performing class of models were those utilising molecular descriptors alone or in combination with protein target descriptors. The random 
test-training split afforded the best-performing models, while performance predicting the toxicity of the rare scaffolds and single source test sets 
was lower
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attribute to challenging nature of testing compounds 
with distinct chemistry from model training as encapsu-
lated by their disparate scaffolds. The single source test 
set also achieved lower validation metrics than the ran-
dom test set, with a reduction in the CCR from 0.85 to 
0.75 respectively, which is only 0.03 higher than the per-
formance obtained on the rare scaffold test set. Hence, 
taken together, our findings show that physico-chemical 
descriptors are a powerful feature set for learning the 
GHS toxicity classifications. This is despite their lack of 
molecular context, but we attribute this in part to their 
relevance to ADME mechanisms.
The models trained on protein target probabili-
ties achieved good performance overall across the test 
sets (centre-left, green bars in Fig.  6), with ROC AUCs 
between 0.85 and 0.70, average precisions between 
0.71 and 0.51, and CCRs (at the optimum thresholds) 
between 0.77 and 0.65 across the test sets. Despite this, 
ROC AUC, average precision and CCR were each always 
lower than the equivalent value for the model built using 
molecular descriptors for every test set. This result cor-
roborates the finding of our prior work, [11] in which we 
found an average CCR drop of 0.11 across 100 training-
test splits comparing Random Forest models trained on 
molecular descriptors to those trained on protein target 
descriptors.
The predictive performances of the models trained on 
molecular descriptors and the models trained on protein-
target descriptors were further analysed by considering 
only those compounds which were classified differently 
by the two models in any of the training-test set splits, 
using their optimum thresholds. A full list of these com-
pounds is provided in Additional file 3, and summarised 
in Additional file 1: Table S4. It is observed that for such 
compounds, models trained using molecular descriptors 
are generally more likely to make the correct prediction. 
However, this was not the case for toxic compounds in 
the rare scaffolds test set (for which the protein-target 
descriptor-trained model made the correct prediction 
61.2% of the time) and toxic compounds in the single 
source test set (for which the protein-target descriptor-
trained model made the correct prediction 62.1% of the 
time). Where the two models disagreed on nontoxic 
compounds in these test sets, the molecular descriptor-
trained models more frequently made the correct classifi-
cation (78.3% of cases for the rare scaffolds set and 74.7% 
of cases for the single source set). For compounds within 
the random test set where the two classifiers disagreed, 
the molecular descriptor-trained model performed bet-
ter on both toxic and nontoxic compounds (88.2% and 
60.6% correct, respectively). However, these compounds 
were the only ones for which the protein-target descrip-
tor-trained model made a larger proportion of correct 
predictions on nontoxic than toxic compounds—though 
it was out-performed by the very strong molecular 
descriptor-trained model (ROC AUC of 0.92) in each 
case.
In contrast to the aforementioned models, the mod-
els built using data derived from in  vitro data from the 
Tox21 project exhibited comparatively poor predictivity 
across the test sets (centre-right, red bars in Fig. 6), with 
ROC AUCs varying from 0.61 to 0.57, average precision 
scores varying from 0.40 to 0.36, and CCRs at the opti-
mum threshold varying from 0.57 to 0.55. These results 
indicate that the model performed only slightly better 
than a random classifier, which is particularly evident in 
the ROC plots in Additional file 1: Fig. S2. Though this is 
a disappointing result, it reflects the smaller separations 
observed between classes seen in earlier exploratory 
analyses (Fig.  5). Indeed, there has been mixed success 
in the literature when attempting to use high-throughput 
screening assays to predict in  vivo toxicity. In order to 
link our work to existing studies, we consider the review 
of Thomas et al. [56] who found in their comprehensive 
review of chemicals and assays provided under Tox-
Cast phase I (a closely related endeavour to the Tox21 
project) that those assays have “limited applicability for 
predicting in  vivo chemical hazards using standard sta-
tistical classification methods.” In contrast, the study of 
Huang et al. [55] which reported variable success utiliz-
ing Tox21 assays alone to predict in vivo endpoints found 
that “combing structure and activity data resulted in 
better models than those built with structure or activity 
data alone” for most of the endpoints they studied. The 
difference in results may be surprising given the overlap 
between the compound set and the Tox21 assays, how-
ever this previous study differed from ours in that they 
made use of a Self-Organizing Map-based approach in 
contrast to our Random Forest, and different toxicity 
endpoints were considered. It is reasonable to conclude 
that the success of utilizing the Tox21 assay data depends 
on optimizing the analysis for that purpose, rather than 
comparing their performance as simply another class of 
descriptor in a study such as this. Moreover, the such 
qHTS assay data has applications beyond predictive 
modelling, including deriving putative mechanisms for 
adverse events [57].
We also generated a fourth class of models using both 
molecular and protein target descriptor sets. The pre-
dictive performance of this model class is also given in 
Table  4 and illustrated by the far right, purple bars in 
Fig.  6. Performance measured by ROC AUC, average 
precision and CCR for this class of model tended to be 
very similar to the molecular descriptors-only model 
class across the three test sets (differing by at most 0.03), 
though sensitivity and specificity showed more variation 
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(differing by at most 0.19 and 0.18, respectively). The 
maximum discrepancy occurred for the rare scaffold set, 
for which the combination model exhibited a sensitivity 
0.19 higher than the molecular descriptor only model, 
and a selectivity 0.18 lower. Overall, however, the CCR 
remained comparable.
Finally, to examine the dependence of these results 
on the randomness in the division of test and train-
ing instances, the training–testing routines were per-
formed as above for 40 further models: 20 using further 
class-stratified random splits, and 20 using further sin-
gle-source splits (in which a class-stratified random sub-
sample of single-source compounds are selected for the 
test set). Due to the design of the rare scaffold set, it was 
not possible to repeat this split to generate multiple test 
sets. The mean and sample standard deviation (SD) of the 
performance metrics for multiple random-split models 
are given in Additional file 1: Table S5, and for the mul-
tiple single-source splits in Additional file  1: Table  S6. 
These results indicate that the performance of the mod-
els analysed in detail elsewhere in this study are broadly 
representative of other random splits that might have 
been chosen. In particular, the same relative performance 
trends for the models trained both on varying descriptor 
sets and varying training sets are observed in the models 
analysed in detail and in the summary statistics. One 
key observation is that, on average, models trained using 
only molecular descriptors and models trained using 
both molecular and protein-target descriptors perform 
very similarly on average for both random splits [mean 
ROC AUC of 0.941 and 0.913 (SD of 0.013 in each case), 
respectively] and single source splits [mean ROC AUC of 
0.851 and 0.852 (SD of 0.013 in each case again), respec-
tively]. The average performances of models trained 
using the Tox21 assay descriptors remained low, with the 
best average performance seen in the random test sets 
producing a ROC AUC of 0.619 (SD of 0.034) and a CCR 
of 0.619 (SD of 0.029).
The natural question arising from these results is 
whether the additional complexity introduced by inte-
grating protein target bioactivity probabilities into the 
molecular descriptor set is worthwhile, given that the 
effect on predictive performance is minimal (or margin-
ally detrimental, for certain metrics). Table  5 compares 
the most important features, determined according to 
the expected fraction of decisions utilising that feature, in 
the two most predictive models studied in detail here: the 
model using chemical descriptors alone and the model 
using chemical and protein target descriptors in com-
bination, both built using the random test set split. This 
Table 5 Highest-importance features in  the  two Random Forest classifiers with  the  highest ROC AUC scores, i.e. 
those generated using the  random test-training set split using (a) molecular descriptors only  and  (b) both  molecular 
and protein target descriptors
The table illustrates the difference in interpretability between the two classes of descriptors, since molecular descriptors may be either be too broad to interpret or 
nontrivial to understand, while protein target descriptors provide a specific biological hypothesis which can be subsequently tested to validate a mechanism of action




(a) Random test set, molecular descriptors a_nN: Number of nitrogen atoms
Q_RPC-: Relative negative partial charge
a_ICM: Atom information content (mean)
h_pavgQ: Average total charge sum across protonation states at pH 7
GCUT_PEOE_0: First GCUT descriptor calculated from the eigenvalues of a modified 
graph distance adjacency matrix where the diagonal takes the values of the partial 
charges
n/a
(b) Random test set, molecular and pro-
tein target descriptors
Q_RPC-: Relative negative partial charge
a_nN: Number of nitrogen atoms
GCUT_SLOGP_0: First GCUT descriptor calculated using atomic contributions to logP 
instead of partial charge
bpol: Sum of the absolute value of the difference between atomic polarizabilities of all 
bonded atoms in the molecule














P11473: Vitamin D3 
receptor
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table allows one potentially benefit of including protein 
target descriptors to be examined: the potential for an 
increase in model interpretability afforded by including 
protein target descriptors.
While the MOE-generated molecular descriptors are 
evidently highly predictive for the data set employed in 
the present study, and therefore of great utility where 
the priority is simply the accuracy of the model, it’s not 
immediately obvious what some of the more esoteric 
descriptors represent (e.g. connectivity indices), nor 
how they might relate to acute oral toxicity. This means 
that generating any further insight from these models is 
a challenge. In contrast, as discussed above, protein tar-
get descriptors can be more readily interpreted through 
literature validation. Two of the most of important pro-
tein targets were not previously identified through the 
exploration of descriptor spaces, namely Tyrosine-pro-
tein phosphatase non-receptor type 1, a kinase linked 
with cytoskeletal machinery and interferon pathways 
(GO:0060338) [58], and Prostaglandin G/H synthase 
1 which has links to cellular stress events [59]. Three of 
the five were previously identified in the aforementioned 
nearest-neighbour and LDA analysis (Nuclear receptor 
ROR-gamma, Retinal dehydrogenase 1 and Vitamin D3 
receptor), which illustrates that the RF algorithm is able 
to identify these target descriptors as an important fea-
ture to separated toxicity classes in addition to its pre-
dictive functionality. The targets identified in this work, 
via the feature importance and descriptor distribution 
analysis, share overlap with the cytotoxic target enrich-
ment analysis (Fisher Test) presented in the complete list 
included in Mervin et  al. [5], namely DNA dC → dU-
editing enzyme APOBEC-3F, Glucagon-like peptide 1 
receptor and Tyrosine-protein phosphatase non-receptor 
type 1, in addition to the histone deacetylases 5 and 6, as 
identified in both Mervin et al. and Liggi et al. [4, 5].
Conclusions
We have presented the collation of a novel dataset, not 
previously analysed, which comprised acute toxicity 
labels (derived from GHS data made available by regula-
tory authorities), chemical structures and qHTS results 
from Tox21. Molecular descriptors were derived from the 
chemical structures, compounds were annotated protein 
target descriptors using in silico target prediction, and 
the qHTS results were summarised into a descriptor set.
In our exploration of the descriptor dataset, we found 
those compounds with a GHS-derived acute oral toxicity 
labels were not substantially more or less druglike than 
the full ToxCast & Tox21 chemical library. We found that 
acute oral toxicity, as encoded by the GHS system, was 
not well aligned with the FAFDrugs4 toxicophore-based 
screen. In contrast, a subset of the toxicophores from the 
ToxAlerts server exhibited a modest relationship with 
GHS-encoded acute oral toxicity. We therefore conclude 
that toxicophore-based screens cannot alone discern the 
acute toxicity encoded within the GHS. We found that 
the acute oral toxicity classes derived from GHS data 
were partially linearly separable in chemical and pro-
tein-target space, as illustrated using nearest-neighbour 
distance distributions and linear discriminant analyses. 
Little separation was observed in the Tox21 descriptor 
space, in agreement with our previous studies.
Predictive models could be created by training Ran-
dom Forest models on the dataset using molecular 
descriptors and protein target bioactivity probabilities as 
input features, with the model trained on the molecular 
descriptors outperforming that trained on the bioactivi-
ties (CCRs of 0.85–0.72 compared to 0.77–0.65). How-
ever, the qHTS data from the Tox21 assays could not be 
successfully employed in GHS class prediction, with the 
Random Forest model trained using these as features 
exhibiting a CCR little better than a random guess. We 
conclude from this that the endpoints captured by the 
Tox21 project may not be relevant to the acute in  vivo 
toxicity encoded by the GHS classifications, or else that 
the relationship between the two may not be captured 
by the simplistic application of the Tox21 assay results 
as features in a supervised machine learning algorithm 
as expected from the separations observed in the three 
spaces.
A combined model trained on both chemical descrip-
tors and protein target bioactivity descriptors had simi-
lar predictive performance to that trained on chemical 
descriptors only. This result was confirmed by measur-
ing the average performance of 40 further models trained 
and tested on repeated randomised splits. We suggested 
that, given that the performance of the combined model 
was comparable with the chemistry-only model, such 
a combined model may be primarily useful due to the 
increased interpretability of the feature importance 
extractable from the model. The five most relevant pro-
tein target descriptors had links to toxicity in the litera-
ture. Further work on this dataset may focus on exploring 
the degree to which this interpretability can be harnessed 
toward interpretability and mode-of-action hypothesis 
generation on a compound-by compound basis. We have 
made the dataset publicly available to this end.
Additional files
Additional file 1. Supplementary information. 
Additional file 2. Research code and data. 
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Additional file 3. List of compounds for which molecular and protein 
target models disagree.
Abbreviations
CCR : (class-balanced) correct classification rate, i.e. the mean of sensitivity and 
specificity; ECHA: European Chemicals Agency; JP NITE: Japan’s National Insti-
tution of Technology and Evaluation; LDA: linear discriminant analysis; NZ EPA: 
New Zealand’s Environmental Protection Authority; ROC: receiver operating 
characteristic curve; ROC AUC : area under the receiver operating characteristic 
curve; SWA: Safe Work Australia.
Acknowledgements
The authors thank the organisers of the 11th International Conference on 
Chemical Structures for providing an opportunity to present their work, 
Avid M. Afzal and Ines Smit for helpful conversations, Ben Alexander-Dann 
for proofreading the manuscript, and Philip Judson of Lhasa Ltd for a useful 
exchange of emails.
Authors’ contributions
CHGA undertook the main research and analyses presented in this study and 
drafted the manuscript. SM contributed to ToxAlert data collation and analysis. 
LHM developed the PIDGIN v2 models, provided guidance on the analysis and 
contributed to the drafting of the manuscript. Overall supervision of the work 
was provided by AB. All authors read and approved the final manuscript.
Funding
Funding for the work was provided by the CEFIC Long-range Research Initia-
tive (CEFIC LRI Award 2012 to AB).
Availability of data and materials
The molecular and protein target descriptors, and the regulator-derived GHS 
toxicity annotations used in this article are available in the Additional files. The 
Tox21 assay data is available on PubChem, via the assay IDs listed in Additional 
File 1: Table S1.
Competing interests
The authors declare that they have no competing interests.
Received: 3 December 2018   Accepted: 15 May 2019
References
 1. The European Union (2006) Regulation (EC) No 1907/2006 of the Euro-
pean Parliament and of the Council of 18 December 2006 concerning 
the Registration, Evaluation, Authorisation and Restriction of Chemicals 
(REACH), establishing a European Chemicals Agency, amending Directive 
1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Com-
mission Regulation (EC) No 1488/94 as well as Council Directive 76/769/
EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 
2000/21/EC. Off J Eur Union 49:1–849
 2. Kavlock RJ, Bahadori T, Barton-Maclaren TS et al (2018) Accelerating the 
pace of chemical risk assessment. Chem Res Toxicol 31:287–290. https ://
doi.org/10.1021/acs.chemr estox .7b003 39
 3. Varnek A, Baskin II (2012) Machine learning methods for property predic-
tion in chemoinformatics: Quo Vadis? J Chem Inf Model 52:1413–1437. 
https ://doi.org/10.1021/ci200 409x
 4. Liggi S, Drakakis G, Koutsoukas A et al (2014) Extending in silico mecha-
nism-of-action analysis by annotating targets with pathways: application 
to cellular cytotoxicity readouts. Future Med Chem 6:2029–2056. https ://
doi.org/10.4155/fmc.14.137
 5. Mervin LH, Cao Q, Barrett IP et al (2016) Understanding cytotoxicity and 
cytostaticity in a high-throughput screening collection. ACS Chem Biol 
11:3007–3023. https ://doi.org/10.1021/acsch embio .6b005 38
 6. Hong H, Thakkar S, Chen M, Tong W (2017) Development of decision 
forest models for prediction of drug-induced liver injury in humans using 
a large set of FDA-approved drugs. Sci Rep 1(7):17311
 7. Lounkine E, Keiser MJ, Whitebread S et al (2012) Large-scale prediction 
and testing of drug activity on side-effect targets. Nature 486:361–367. 
https ://doi.org/10.1038/natur e1115 9
 8. Mayr A, Klambauer G, Unterthiner T, Hochreiter S (2016) DeepTox: toxic-
ity prediction using deep learning. Front Environ Sci 3:24. https ://doi.
org/10.3389/fenvs .2015.00080 
 9. Sedykh AY, Zhu H, Tang H et al (2011) Use of in vitro HTS-derived concen-
tration-response data as biological descriptors improves the accuracy of 
QSAR models of in vivo toxicity. Environ Health Perspect 119:364–370. 
https ://doi.org/10.1289/ehp.10024 76
 10. Low YS, Sedykh AY, Rusyn I, Tropsha A (2014) Integrative approaches for 
predicting in vivo effects of chemicals from their structural descriptors 
and the results of short-term biological assays. Curr Top Med Chem 
14:1356–1364
 11. Allen CHG, Koutsoukas A, Cortes-Ciriano I et al (2016) Improving the 
prediction of organism-level toxicity through integration of chemical, 
protein target and cytotoxicity qHTS data. Toxicol Res 5:883–894. https ://
doi.org/10.1039/C5TX0 0406C 
 12. Richard AM, Judson RS, Houck KA et al (2016) ToxCast chemical land-
scape: paving the road to 21st century toxicology. Chem Res Toxicol 
29:1225–1251. https ://doi.org/10.1021/acs.chemr estox .6b001 35
 13. United Nations Economic Commission for Europe Secretariat (2011) 
Globally harmonized system of classification and labelling of chemicals 
(GHS), 4th edn. United Nations, New York
 14. Luechtefeld T, Maertens A, Russo DP et al (2016) Global analysis of pub-
licly available safety data for 9,801 substances registered under REACH 
from 2008–2014. Altex 1(33):95–109. https ://doi.org/10.1093/nar/gku40 1
 15. Drwal MN, Banerjee P, Dunkel M et al (2014) ProTox: a web server for the 
in silico prediction of rodent oral toxicity. Nucleic Acids Res 42:W53–W58. 
https ://doi.org/10.1093/nar/gku40 1
 16. USEPA (2018) ToxCast & Tox21 chemicals distributed structure-searchable 
toxicity database from DSSTox_20151019. http://www2.epa.gov/chemi 
cal-resea rch/toxic ity-forec aster -toxca sttm-data. Data Released October 
2015
 17. Molecular Operating Environment (MOE) 2018.01, Chemical Computing 
Group ULC. http://www.chemc omp.com/index .htm
 18. Mervin LH, Bulusu KC, Kalash L et al (2017) Orthologue chemical space 
and its influence on target prediction. Bioinformatics 34:1–8. https ://doi.
org/10.1093/bioin forma tics/btx52 5
 19. Kim S, Thiessen PA, Bolton EE et al (2016) PubChem substance and 
compound databases. Nucleic Acids Res 44:D1202–D1213. https ://doi.
org/10.1093/nar/gkv95 1
 20. Austin CP, Tice RR, Kavlock RJ, Bucher JR (2013) Improving the human 
hazard characterization of chemicals: a Tox21 update. Environ Health 
Perspect 121:756–765. https ://doi.org/10.1289/ehp.12057 84
 21. European Chemicals Agency. http://echa.europ a.eu/. Accessed 26 Apr 
2018
 22. New Zealand Environmental Protection Authority. https ://www.epa.govt.
nz/. Accessed 26 Apr 2018
 23. Japanese National Institute of Technology and Evaluation (NITE). https ://
www.nite.go.jp/index -e.html. Accessed 26 April 2018
 24. Safe Work Australia. https ://www.safew orkau stral ia.gov.au/. Accessed 26 
April 2018
 25. New Zealand Environmental Protection Authority (2017) Hazardous 
substances (classification) notice 2017. https ://www.epa.govt.nz/asset 
s/Uploa ds/Docum ents/Hazar dous-Subst ances /EPA-Notic es/Hazar dous-
Subst ances -Minim um-Degre es-of-Hazar d-Notic e-2017.pdf. Accessed 20 
Nov 2018
 26. OECD (2006). eChemPortal. https ://www.echem porta l.org. Accessed 26 
Apr 2018
 27. JChem 17.25.0 2017. ChemAxon. http://www.chema xon.com
 28. Heller SR, McNaught A, Pletnev I et al (2015) InChI, the IUPAC interna-
tional chemical identifier. J Cheminf 7:23. https ://doi.org/10.1186/s1332 
1-015-0068-4
 29. Gaulton A, Hersey A, Nowotka M et al (2017) The ChEMBL database in 
2017. Nucleic Acids Res 45:D945–D954. https ://doi.org/10.1093/nar/
gkw10 74
 30. Sander T, Freyss J, von Korff M, Rufener C (2015) DataWarrior: an open-
source program for chemistry aware data visualization and analysis. J 
Chem Inf Model 55:460–473. https ://doi.org/10.1021/ci500 588j
Page 19 of 19Allen et al. J Cheminform           (2019) 11:36 
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 31. Lagorce D, Bouslama L, Becot J et al (2017) FAF-Drugs4: free ADME-tox 
filtering computations for chemical biology and early stages drug discov-
ery. Bioinformatics 33:3658–3660. https ://doi.org/10.1093/bioin forma tics/
btx49 1
 32. Sushko I, Salmina E, Potemkin VA et al (2012) ToxAlerts: a web server 
of structural alerts for toxic chemicals and compounds with poten-
tial adverse reactions. J Chem Inf Model 52:2310–2316. https ://doi.
org/10.1021/ci300 245q
 33. Sushko I, Novotarskyi S, Körner R et al (2011) Online chemical modeling 
environment (OCHEM): web platform for data storage, model develop-
ment and publishing of chemical information. J Comput Aided Mol Des 
25:533–554. https ://doi.org/10.1007/s1082 2-011-9440-2
 34. Salmina E, Haider N, Tetko I (2015) Extended Functional groups (EFG): 
an efficient set for chemical characterization and structure-activity 
relationship studies of chemical compounds. Molecules 21:1. https ://doi.
org/10.3390/molec ules2 10100 01
 35. Oliphant TE (2007) Python for scientific computing. Comput Sci Eng 
9:10–20. https ://doi.org/10.1109/mcse.2007.58
 36. Pedregosa F, Varoquaux G, Gramfort A et al (2011) Scikit-learn: machine 
learning in python. J Mach Learn Res 12:2825–2830
 37. Cronin MTD (2013) Computational toxicology is now inseparable from 
experimental toxicology. Altern Lab Anim 41:1–4
 38. Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecu-
lar frameworks. J Med Chem 39:2887–2893. https ://doi.org/10.1021/
jm960 2928
 39. RDKit: Open-source cheminformatics. http://www.rdkit .org
 40. Svetnik V, Liaw A, Tong C et al (2003) Random Forest: a classification and 
regression tool for compound classification and QSAR modeling. J Chem 
Inf Comput Sci 43:1947–1958. https ://doi.org/10.1021/ci034 160g
 41. Sharratt M (1988) Assessing risks from data on other exposure routes: 
possibilities and limitations of using toxicity data derived from one expo-
sure route in assessing risks from other exposure routes. Regul Toxicol 
Pharmacol 8:399–407. https ://doi.org/10.1016/0273-2300(88)90038 -4
 42. Waring MJ, Arrowsmith J, Leach AR et al (2015) An analysis of the attrition 
of drug candidates from four major pharmaceutical companies. Nat Rev 
Drug Discov 14:475–486. https ://doi.org/10.1038/nrd46 09
 43. Schwöbel JAH, Koleva YK, Enoch SJ et al (2011) Measurement and 
estimation of electrophilic reactivity for predictive toxicology. Chem Rev 
111:2562–2596. https ://doi.org/10.1021/cr100 098n
 44. Alves V, Muratov E, Capuzzi S et al (2016) Alarms about structural alerts. 
Green Chem Int J Green Chem Resour 18:4348–4360. https ://doi.
org/10.1039/C6GC0 1492E 
 45. Stepan AF, Walker DP, Bauman J et al (2011) Structural Alert/reactive 
metabolite concept as applied in medicinal chemistry to mitigate the risk 
of idiosyncratic drug toxicity: a perspective based on the critical examina-
tion of trends in the top 200 drugs marketed in the united states. Chem 
Res Toxicol 24:1345–1410. https ://doi.org/10.1021/tx200 168d
 46. Patterson DE, Cramer RD, Ferguson AM et al (1996) Neighborhood behav-
ior: a useful concept for validation of “molecular diversity” descriptors. J 
Med Chem 39:3049–3059. https ://doi.org/10.1021/jm960 290n
 47. Singh S, Brocker C, Koppaka V et al (2013) Aldehyde dehydrogenases in 
cellular responses to oxidative/electrophilicstress. Free Radic Biol Med 
56:89–101. https ://doi.org/10.1016/j.freer adbio med.2012.11.010
 48. Ryoo I-G, Kwak M-K (2018) Regulatory crosstalk between the oxidative 
stress-related transcription factor Nfe2l2/Nrf2 and mitochondria. Toxicol 
Appl Pharmacol 359:24–33. https ://doi.org/10.1016/j.taap.2018.09.014
 49. Zhang Y, Luo X-Y, Wu D-H, Xu Y (2015) ROR nuclear receptors: structures, 
related diseases, and drug discovery. Acta Pharmacol Sin 36:71–87. https 
://doi.org/10.1038/aps.2014.120
 50. Zou J, Wang C, Ma X et al (2017) APOBEC3B, a molecular driver 
of mutagenesis in human cancers. Cell Biosci 7:1593. https ://doi.
org/10.1186/s1357 8-017-0156-4
 51. Kemmis CM, Salvador SM, Smith KM, Welsh J (2006) Human mammary 
epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxy-
vitamin D-3, the major circulating form of vitamin D-3. J Nutr 136:887–
892. https ://doi.org/10.1093/jn/136.4.887
 52. Hendrick E, Peixoto P, Blomme A et al (2017) Metabolic inhibitors accen-
tuate the anti-tumoral effect of HDAC5 inhibition. Oncogene 36:4859–
4874. https ://doi.org/10.1038/onc.2017.103
 53. Namdar M, Perez G, Ngo L, Marks PA (2010) Selective inhibition of histone 
deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed 
cells to anticancer agents. Proc Natl Acad Sci USA 107:20003–20008. 
https ://doi.org/10.1073/pnas.10137 54107 
 54. Li Y, Hansotia T, Yusta B et al (2003) Glucagon-like peptide-1 receptor 
signaling modulates beta cell apoptosis. J Biol Chem 278:471–478. https 
://doi.org/10.1074/jbc.M2094 23200 
 55. Huang R, Xia M, Sakamuru S et al (2016) Modelling the Tox21 10 K chemi-
cal profiles for in vivo toxicity prediction and mechanism characteriza-
tion. Nat Commun 7:10425. https ://doi.org/10.1038/ncomm s1042 5
 56. Thomas RS, Black MB, Li L et al (2012) A comprehensive statistical analysis 
of predicting in vivo hazard using high-throughput in vitro Screening. 
Toxicol Sci 128:398–417. https ://doi.org/10.1093/toxsc i/kfs15 9
 57. Svensson F, Zoufir A, Mahmoud S et al (2018) Information-derived 
mechanistic hypotheses for structural cardiotoxicity. Chem Res Toxicol 
31:1119–1127. https ://doi.org/10.1021/acs.chemr estox .8b001 59
 58. Nievergall E, Janes PW, Stegmayer C et al (2010) PTP1B regulates Eph 
receptor function and trafficking. J Cell Biol 191:1189–1203. https ://doi.
org/10.1083/jcb.20100 5035
 59. Choi S-H, Aid S, Bosetti F (2009) The distinct roles of cyclooxyge-
nase-1 and -2 in neuroinflammation: implications for translational 
research. Trends Pharmacol Sci 30:174–181. https ://doi.org/10.1016/j.
tips.2009.01.002
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
